Bull
$7.29
Scenario price
$6.500
+0.143 (+2.20%)At close
Teladoc Health, Inc. provides virtual healthcare services. Its segments include Teladoc Health Integrated Care (Integrated Care) and BetterHelp. Integrated Care segment includes a suite of global virtual medical services including general medical, expert medical services, specialty medical, chronic condition management, mental health, and enabling technologies and enterprise telehealth solutions for hospitals and health systems. Services in this segment are distributed on a B2B basis. BetterHelp segment includes direct-to-consumer mental health platform. The online counseling and therapy services are provided via its network of over 35,000 licensed clinicians leveraging its platform for Web, mobile app, phone, and text-based interactions. Its Teladoc Health family of brands, including Teladoc and BetterHelp, deliver access to advice and resolution for an array of healthcare needs. Its Telecare brand is a tech-enabled provider of specialist and allied health care via virtual delivery.
Teladoc Health Inc is currently not a strong buy. The stock is trading at $6.50, with a forward P/E ratio of 303.03, indicating high valuation concerns. Additionally, the recent news of a 21% drop in share price due to a revenue miss and lowered guidance raises significant red flags. The company also faces a securities fraud investigation, which could further impact its stock price.
Citi
$11
2026-08-03
Citi
2026-08-03
Price Target
$11
Jefferies
$8
2026-07-30
Jefferies
2026-07-30
Price Target
$8
Evercore ISI
$10
2026-07-30
Evercore ISI
2026-07-30
Price Target
$10
Citi
$11
2026-07-23
Citi
2026-07-23
Price Target
$11
Canaccord
$11
2026-07-21
Canaccord
2026-07-21
Price Target
$11
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Investigation into Securities Fraud Claims Against Teladoc Health, Inc.

Investigation into Teladoc Health Officers' Fiduciary Duties

Investigation into Securities Fraud Claims Against Teladoc Health, Inc.

Teladoc Health Shares Plunge 28% After Q2 Revenue Miss and Guidance Cut

Pomerantz Investigates Securities Fraud Claims Against Teladoc Health
Teladoc Health, Inc. provides virtual healthcare services. Its segments include Teladoc Health Integrated Care (Integrated Care) and BetterHelp. Integrated Care segment includes a suite of global virtual medical services including general medical, expert medical services, specialty medical, chronic condition management, mental health, and enabling technologies and enterprise telehealth solutions for hospitals and health systems. Services in this segment are distributed on a B2B basis. BetterHelp segment includes direct-to-consumer mental health platform. The online counseling and therapy services are provided via its network of over 35,000 licensed clinicians leveraging its platform for Web, mobile app, phone, and text-based interactions. Its Teladoc Health family of brands, including Teladoc and BetterHelp, deliver access to advice and resolution for an array of healthcare needs. Its Telecare brand is a tech-enabled provider of specialist and allied health care via virtual delivery. It operates in the Healthcare sector (SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE industry).
Teladoc Health Inc is currently not a strong buy. The stock is trading at $6.50, with a forward P/E ratio of 303.03, indicating high valuation concerns. Additionally, the recent news of a 21% drop in share price due to a revenue miss and lowered guidance raises significant red flags. The company also faces a securities fraud investigation, which could further impact its stock price.
13 analysts cover TDOC: 10 rate it Buy, 3 Hold and 0 Sell. The average price target is 8.91.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.